Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
  1. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $72.85 ($145,700)
  2. 4 Planned sale Chief Executive Officer sold 10,000 shares at an average $69.08 ($690,847)
  3. 4 Planned sale Chief Executive Officer sold 44,980 shares at an average $82.86 ($3,727,251)
  4. 4 Shares withheld for taxes President and CFO gave up 22,781 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 36,237 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Accounting Officer gave up 4,714 shares (to pay taxes)
  7. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $80.06 ($160,120)
  8. 4 Planned sale Director sold 17,167 shares at $84.00 ($1,442,028)
  9. 4 Planned sale Director sold 148,589 shares at an average $88.54 ($13,156,008)
  10. 4 Planned sale Director sold 39,363 shares at an average $69.92 ($2,752,270)
  11. 4 Planned sale Director sold 5,004 shares at an average $68.25 ($341,524)
  12. 4 Grant or award Director acquired 3,990 shares (grant or award)
  13. 4 Grant or award Director acquired 3,990 shares (grant or award)
  14. 4 Grant or award Director acquired 3,990 shares (grant or award)
  15. 4 Grant or award Director acquired 3,990 shares (grant or award)
  16. 4 Grant or award Director acquired 3,990 shares (grant or award)
  17. 4 Grant or award Director acquired 3,990 shares (grant or award)
  18. 4 Grant or award Director acquired 3,990 shares (grant or award)
  19. 4 Grant or award Director acquired 3,990 shares (grant or award)
  20. 4 Grant or award Director acquired 3,990 shares (grant or award)

Page 1 of 23 · 449 filings